Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2484701 | 1.00 | CNR2 (1.00) | CNR2 | |
| SCHEMBL2510556 | 0.89 | CNR2 (1.00) | CNR2 | |
| SCHEMBL2181888 | 0.89 | CNR2 (0.81) | CNR2 | |
| SCHEMBL2510558 | 0.89 | CNR2 (1.00) | CNR2 | |
| SCHEMBL2181896 | 0.89 | CNR2 (0.81) | CNR2 | |
| SCHEMBL3027807 | 0.87 | CNR2 (0.76) | CNR2 | |
| SCHEMBL3027805 | 0.87 | CNR2 (0.76) | CNR2 | |
| SCHEMBL2506124 | 0.84 | CNR2 (1.00) | CNR2 | |
| SCHEMBL2506121 | 0.84 | CNR2 (1.00) | CNR2 | |
| SCHEMBL2184940 | 0.80 | CNR2 (1.00) | CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3026046-A1 | THIAZOLES AS CANNABINOID RECEPTOR LIGANDS | AbbVie Inc. (US) | 2016-06-01 | — | — | EP | claimed |
| US-8895592-B2 | Compounds as cannabinoid receptor ligands | ABBVIE INC. (US) | 2014-11-25 | — | — | US | claimed |
| EP-2376462-A1 | Thiazoles as cannabinoid receptor ligands | Abbott Laboratories (US) | 2011-10-19 | — | — | EP | claimed |
| US-20100216760-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2010-08-26 | — | — | US | claimed |
| WO-2010071783-A1 | THIAZOLES AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2010-06-24 | — | — | WO | claimed |
| EP-3026046-A1 | THIAZOLES AS CANNABINOID RECEPTOR LIGANDS | AbbVie Inc. (US) | 2016-06-01 | — | — | EP | disclosed |
| EP-2376462-B1 | THIAZOLES AS CANNABINOID RECEPTOR LIGANDS | ABBVIE INC (US) | 2015-12-16 | — | — | EP | disclosed |
| US-8895592-B2 | Compounds as cannabinoid receptor ligands | ABBVIE INC. (US) | 2014-11-25 | — | — | US | disclosed |
| EP-2376462-A1 | Thiazoles as cannabinoid receptor ligands | Abbott Laboratories (US) | 2011-10-19 | — | — | EP | disclosed |
| US-20100216760-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2010-08-26 | — | — | US | disclosed |
| WO-2010071783-A1 | THIAZOLES AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2010-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216760-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | CNR1, CNR2, OPRL1 | CNR2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.